SEC Filing: Stephanie O'Brien Stephanie Monaghan - Ownership Change in Apellis Pharmaceuticals, Inc.

This SEC filing details a transaction by Stephanie O'Brien, a director at Apellis Pharmaceuticals, Inc. (APLS). On April 6, 2026, 5,750 shares of Common Stock were acquired. This acquisition, coded as 'J', was a distribution of shares from a trust to an account held directly by O'Brien's spouse. Despite the transaction, O'Brien's beneficial ownership remains unchanged due to the nature of the distribution, as indicated by footnote F1. Following this transaction, O'Brien directly owns 25,666 shares of Common Stock. The transaction was reported on Form 4, with the signature date of April 8, 2026.